Corporate VC · Cambridge (United States), Paris (France) · Founded 2001
Sanofi Ventures is the corporate venture capital arm of Sanofi. They invest in top-tier biotech and digital health companies focusing on improving patient care and transforming healthcare. Their investments span from Seed to Series B and beyond, offering portfolio companies access to Sanofi's expertise.
Seed, Series A, Series B
Analytics, BioTech, Digital Health, Pharma, Vaccines
Eligo Bioscience, Granite Bio, Muna Therapeutics, NodThera, OMass Therapeutics, QurAlis, T-Therapeutics, Therini Bio, Lava Therapeutics, Aetion, Carbon Health, Click Tx, Empatica, Medisafe, Nucleai, Omada, i2O Therapeutics, Minervax, Sudo Bio, Avilar Therapeutics, Matchpoint Therapeutics, Nextpoint Therapeutics, Abcuro, Expansion Therapeutics, Glycomine, ReCode Therapeutics, Rome Therapeutics, Navitor Pharmaceuticals, Nura Bio, Vrata, Escient Pharmaceuticals, Q32 Bio, Icosavax, Kymera Therapeutics, Ovid Therapeutics, Science 37, Lysosomal Therapeutics Inc, Theseus, Ikena, Synthekine, Vanqua Bio, Kala Pharmaceuticals, Neuronetics, Lyra Therapeutics, Microchips Biotech, Arsenal Medical, CAMP4 Therapeutics, Veralox, Cerevel, Nuvalent, Amylyx, Savara Pharmaceuticals